In this study, the IFN-γ levels in plasma, the IFNG rs2069727 T/C variation, which is thought to affect this level, and the relative expression levels of hsa-miR-24-3p and hsa-miR-181 d-3p were examined in terms of their contribution to MS risk and disability scores. This evidence concerns the gene IFNG and myeloid sarcoma.